BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2426376)

  • 1. [Embryonal carcinoma (Higuchi, Kato) of the ovary, clinical analysis and recent improvement of treatment using alpha FP as a tumor marker].
    Ohta M; Kano T; Nishida Y; Sakakibara K; Tomoda Y; Miyazaki T; Arii Y; Kazeto S; Iida S; Umemura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):887-95. PubMed ID: 2426376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
    Ohta M; Tomoda Y; Kano T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
    Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological study of ovarian embryonal carcinoma (Higuchi-Kato)].
    Tanaka Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1511-8. PubMed ID: 7130773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian tumors in children and adolescents less than 20 years age.
    Yakushiji M; Matsukuma T; Abe M; Nishida T; Nishimura H; Tsunawaki A; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):833-8. PubMed ID: 7246071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
    Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
    Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ cell malignancies of the ovary.
    Creasman WT; Fetter BF; Hammond CB; Parker RT
    Obstet Gynecol; 1979 Feb; 53(2):226-30. PubMed ID: 216959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature teratoma of the ovary.
    Gershenson DM; del Junco G; Silva EG; Copeland LJ; Wharton JT; Rutledge FN
    Obstet Gynecol; 1986 Nov; 68(5):624-9. PubMed ID: 3763073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonal carcinoma of the ovary: a six-year survival.
    Ueda G; Abe Y; Yoshida M; Fujiwara T
    Int J Gynaecol Obstet; 1990 Mar; 31(3):287-92. PubMed ID: 1690671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary combined chemotherapy following removal of an endodermal sinus tumor or yolk-sac tumor of the ovary (author's transl)].
    Frick R; Rummel H; Wurster K; Kaufmann M
    Geburtshilfe Frauenheilkd; 1976 Nov; 36(11):946-50. PubMed ID: 62689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracranial non-testicular teratoma in childhood and adolescence: introduction of a risk score for stratification of therapy.
    Göbel U; Calaminus G; Blohm M; Booss D; Felberbauer F; Hofmann U; Holschneider AM; Willnow U; Harms D
    Klin Padiatr; 1997; 209(4):228-34. PubMed ID: 9293455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of testicular tumors].
    Yoshida K; Kawakami T; Nomura K; Nishimura K; Go M; Takagi Y; Irie A; Murayama M; Iwamura M; Izumi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1396-403. PubMed ID: 3434495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
    Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mixed ovarian germinal neoplasia: adult embryonal carcinoma and dysgerminoma with trophoblasts].
    Martinazzi M; Bertoli G; Crivelli F; Zampatti C; Bersiga A
    Pathologica; 1989; 81(1075):537-42. PubMed ID: 2641155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.